Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) is a publicly traded company on the Shenzhen Stock Exchange, renowned as the first domestic enterprise to develop and manufacture PVP and PVM/MA products. As the third largest global manufacturer of PVP, the company has established itself as a key supplier to the pharmaceutical industry. Its product lines, including KoVidone® and PolyKoVidone®, offer a range of Povidone, Crospovidone, and Copovidone pharmaceutical excipients. The KoVidone®-I (PVP-I) serves as a broad-spectrum biocidal, antifungal, and antiviral agent, while the OraRez® line features PVM/MA Copolymer and its derivatives, catering to functional polymers for bioadhesive and mucoadhesive applications.

Services include:
- Excipients
- Packaging Equipment

Boai NKY Pharmaceuticals Ltd continues to be a pivotal player in the pharmaceutical sector, providing innovative solutions that meet the diverse needs of its clients. For more information, please visit boai-nky.com.